Fujita S, Koguma T, Ohkawa J, Mori K, Kohda T, Kise H, Nishikawa S, Iwakura M, Taira K
National Institute of Bioscience and Human Technology, Ministry of International Trade and Industry, Tsukuba Science City, Japan.
Proc Natl Acad Sci U S A. 1997 Jan 21;94(2):391-6. doi: 10.1073/pnas.94.2.391.
For use of ribozymes in vivo, it is desirable to select functional ribozymes in the cellular environment (in the presence of inhibitory factors and limited concentrations of mandatory Mg2+ ions, etc.). As a first step toward this goal, we developed a new screening system for detection in vivo of an active ribozyme from pools of active and inactive ribozymes using the gene for dihydrofolate reductase (DHFR) as a selective marker. In our DHFR expression vector, the sequence encoding either the active or the inactive ribozyme was connected to the DHFR gene. The plasmid was designed such that, when the ribozyme was active, the rate of production of DHFR was high enough to endow resistance to trimethoprim (TMP). We demonstrated that the active ribozyme did indeed cleave the primary transcript in vivo, whereas the inactive ribozyme had no cleavage activity. Cells that harbored the active-ribozyme-coding plasmid grew faster in the presence of a fixed concentration of TMP than the corresponding cells that harbored the inactive-ribozyme-coding plasmid. Consequently, when cells were transformed by a mixture that consisted of active- and inactive-ribozyme-coding plasmids at a ratio of 1:1, (i) mainly those cells that harbored active ribozymes survived in the presence of TMP and (ii) both active- and inactive-ribozyme-harboring cells grew at an identical rate in the absence of TMP, a demonstration of a positive selection system in vivo. If the background "noise" can be removed completely in the future, the selection system might usefully complement existing selection systems in vitro.
为了在体内使用核酶,期望在细胞环境中(存在抑制因子和有限浓度的必需镁离子等情况下)选择功能性核酶。作为实现这一目标的第一步,我们开发了一种新的筛选系统,利用二氢叶酸还原酶(DHFR)基因作为选择标记,在体内从活性和非活性核酶库中检测活性核酶。在我们的DHFR表达载体中,编码活性或非活性核酶的序列与DHFR基因相连。该质粒的设计使得当核酶具有活性时,DHFR的产生速率足够高,赋予对甲氧苄啶(TMP)的抗性。我们证明活性核酶确实在体内切割初级转录本,而非活性核酶没有切割活性。携带活性核酶编码质粒的细胞在固定浓度的TMP存在下比携带非活性核酶编码质粒的相应细胞生长得更快。因此,当细胞用活性和非活性核酶编码质粒以1:1的比例组成的混合物转化时,(i)主要是那些携带活性核酶的细胞在TMP存在下存活,并且(ii)携带活性和非活性核酶的细胞在没有TMP的情况下以相同的速率生长,这证明了体内的阳性选择系统。如果将来背景“噪音”能够被完全消除,该选择系统可能会有效地补充现有的体外选择系统。